The first major study of a Covid-19 vaccine in the United States began this Monday morning with the administration of one dose to a single patient in Savannah, Georgia, the first inoculation for the Moderna and the National Institutes of Health (NIH) trial, which will evaluate the safety and efficacy of the vaccine in 30,000 people.